All In Biotech

Drug Trial Radar · NCT05127486

A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine

A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine

Last checked: Nov 20, 2026Latest source record: Jun 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 580 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

580

Actual

Start

Dec 6, 2021

Primary completion

May 23, 2023

Study completion May 23, 2023

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Nov 19, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess whether galcanezumab is superior to rimegepant in the prevention of migraine in participants with episodic migraine. The study duration will be approximately 6 months.

Conditions

  • Migraine
  • Episodic Migraine

Interventions

  • GalcanezumabDrug

    Administered SC.

  • RimegepantDrug

    Administered orally.

  • PlaceboDrug

    Administered orally.

  • PlaceboDrug

    Administered SC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With 50% Response Rate Across the 3-month Treatment Period.Time frame: Baseline, Month 1 through Month 3

Locations

77 sites in 1 country. Site status is shown where the registry gives one.

  • Gilbert Neurology

    Gilbert, Arizona

  • Foothills Research Center / CCT Research

    Phoenix, Arizona

  • Alliance for Multispecialty Research, LLC Tempe

    Tempe, Arizona

  • Velocity Clinical Research, Banning

    Banning, California

  • Velocity Clinical Research, Chula Vista

    Chula Vista, California

  • Wr- Pri, Llc

    Encino, California

  • Velocity Clinical Research, San Diego

    La Mesa, California

  • California Medical Clinic for Headache and The Los Angeles Headache Center (Research Facility)

    Los Angeles, California

  • Pharmacology Research Institute

    Newport Beach, California

  • Velocity Clinical Research, North Hollywood

    North Hollywood, California

  • Anderson Clinical Research

    Redlands, California

  • Center for Clinical Trials of Sacramento

    Sacramento, California

  • Velocity Clinical Research, Huntington Park

    Santa Ana, California

  • Encompass Clinical Research

    Spring Valley, California

  • CMR of Greater New Haven, LLC

    Hamden, Connecticut

  • Innovative Research of West Florida

    Clearwater, Florida

  • AMR Miami

    Coral Gables, Florida

  • Accel Research Sites- Clinical Research Unit

    DeLand, Florida

  • Velocity Clinical Research, Hallandale Beach

    Hallandale, Florida

  • Accel Research Sites-LKD CRU

    Lakeland, Florida

  • Visionary Investigators Network

    Miami, Florida

  • Visionary Investigators Network

    Miami, Florida

  • Sensible Healthcare, LLC

    Ocoee, Florida

  • University of South Florida

    Tampa, Florida

  • Palm Beach Research Center

    West Palm Beach, Florida

  • DelRicht Research

    Atlanta, Georgia

  • Better Health Clinical Research

    Newnan, Georgia

  • Meridian Clinical Research

    Savannah, Georgia

  • Chicago Headache Center

    Chicago, Illinois

  • American Health Network of Indiana, LLC - Avon

    Avon, Indiana

  • Deaconess Clinic

    Evansville, Indiana

  • Alliance for Multispecialty Research, LLC El Dorado

    El Dorado, Kansas

  • Alliance for Multispecialty Research, LLC Lexington

    Lexington, Kentucky

  • L-MARC Research Center

    Louisville, Kentucky

  • DelRicht Research

    Covington, Louisiana

  • DelRicht Research

    New Orleans, Louisiana

  • DelRicht Research

    Prairieville, Louisiana

  • Boston Clinical Trials

    Boston, Massachusetts

  • Michigan Headache & Neurological Institute

    Ann Arbor, Michigan

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

Showing 40 of 77 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.